References
Chin, L., Hahn, W. C., Getz, G. & Meyerson, M. Genes Dev. 25, 534–555 (2011).
Grossman, R. L. et al. N. Engl. J. Med. 375, 1109–1112 (2016).
Zhu, J. et al. Nat. Methods 6, 239–240 (2009).
Cerami, E. et al. Cancer Discov. 2, 401–404 (2012).
Zhang, J. et al. Nat. Biotechnol. 37, 367–369 (2019).
Leiserson, M. D. M. et al. Nat. Methods 12, 483–484 (2015).
Wang, Y. E., Kutnetsov, L., Partensky, A., Farid, J. & Quackenbush, J. Cancer Res. 77, e11–e14 (2017).
Streit, M. et al. Bioinformatics 35, 3140–3142 (2019).
Thorvaldsdóttir, H., Robinson, J. T. & Mesirov, J. P. Brief. Bioinform. 14, 178–192 (2013).
Perez-Llamas, C. & Lopez-Bigas, N. PLoS One 6, e19541 (2011).
ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Nature 578, 82–93 (2020).
Zhou, W. et al. Nat. Genet. 50, 591–602 (2018).
Corces, M. R. et al. Science 362, 6413 (2018).
Cieślik, M. & Chinnaiyan, A. M. Nat. Rev. Genet. 19, 93–109 (2018).
Langmead, B. & Nellore, A. Nat. Rev. Genet. 19, 208–219 (2018).
Hoadley, K. A. et al. Cell 173(291–304), e6 (2018).
GTEx Consortium et al. Nature 550, 204–213 (2017).
Vivian, J. et al. Nat. Biotechnol. 35, 314–316 (2017).
Ma, X. et al. Nature 555, 371–376 (2018).
Gao, Q. et al. Cell Rep. 23(227–238), e3 (2018).
Acknowledgements
Research reported in this publication was supported by the National Cancer Institute of the US National Institutes of Health under award numbers 5U24CA180951-04 and 5U24CA210974-02. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This project has also been made possible in part by grant number 2018-182812 from the Chan Zuckerberg Initiative DAF, an advised fund of the Silicon Valley Community Foundation. We would also like to thank AWS Cloud Credits for Research and Google Summer of Code.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Editorial note: This article has been peer reviewed.
Supplementary information
Supplementary Information
Supplementary Figs. 1–10, Supplementary Table 1, Supplementary Note and Supplementary Methods
Rights and permissions
About this article
Cite this article
Goldman, M.J., Craft, B., Hastie, M. et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol 38, 675–678 (2020). https://doi.org/10.1038/s41587-020-0546-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-020-0546-8
- Springer Nature America, Inc.
This article is cited by
-
EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression
Journal of Translational Medicine (2024)
-
Unveiling promising breast cancer biomarkers: an integrative approach combining bioinformatics analysis and experimental verification
BMC Cancer (2024)
-
Machine-learning analysis reveals an important role for negative selection in shaping cancer aneuploidy landscapes
Genome Biology (2024)
-
PheSeq, a Bayesian deep learning model to enhance and interpret the gene-disease association studies
Genome Medicine (2024)
-
The TP53-activated E3 ligase RNF144B is a tumour suppressor that prevents genomic instability
Journal of Experimental & Clinical Cancer Research (2024)